| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,123,000 | 2,403,000 | 2,852,000 | 2,878,000 | | Cost of Revenue | 1,195,000 | 1,418,000 | 1,734,000 | 1,748,000 | | | Gross Profit | 928,000 | 985,000 | 1,118,000 | 1,130,000 | | | Operating Expenses | | Research Development |
-
| 25,000 | 24,000 | 24,000 | | Selling General and Administrative | 269,000 | 281,000 | 332,000 | 364,000 | | Non Recurring | 18,000 | 159,000 |
-
|
-
| | Others | 199,000 | 206,000 | 218,000 | 216,000 | | | | Total Operating Expenses |
-
| 671,000 |
-
|
-
| | | | Operating Income or Loss | 442,000 | 314,000 | 544,000 | 526,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 17,000 | | Earnings Before Interest And Taxes | 442,000 | 314,000 | 544,000 | 543,000 | | Interest Expense | 35,000 | 49,000 | 50,000 | 52,000 | | Income Before Tax | 407,000 | 265,000 | 494,000 | 491,000 | | Income Tax Expense | 114,000 | 67,000 | 139,000 | 137,000 | | Minority Interest | (8,000) | (6,000) | (11,000) | (13,000) | | | | Net Income From Continuing Ops | 290,000 | 200,000 | 355,000 | 349,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 290,000 | 200,000 | 355,000 | 349,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $290,000 | $200,000 | $355,000 | $349,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
